Exicure Inc Sustainability Reports
Exicure, Inc. is a biotechnology company focused on developing nucleic acid therapies and pursuing collaborative therapeutic development agreements. Its research historical focus centered on proprietary Spherical Nucleic Acid technology for immuno-oncology, inflammatory diseases, and genetic disorders.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300IMD6I0V06I2Z87
FIGI: BBG00GTJCSC3
3 reports from 2018 to 2022
